Priapism
What's New
Last Posted: Feb 01, 2024
- Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.
Anirban Basu et al. Ann Intern Med 2024 - Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database.
Lui Jason L, et al. Andrology 2023 0 - Evaluation of sociodemographic, clinical, and laboratory markers of sickle leg ulcers among young nigerians at a tertiary health institution.
Olatunya O S, et al. Nigerian journal of clinical practice 2018 0 (7) 882-887 - Alpha thalassemia, but not ?-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort.
Hatzlhofer Betânia Lucena Domingues, et al. Annals of hematology 2021 0 (4) 921-931 - Sickle Cell Disease: A Review.
Kavanagh Patricia L et al. JAMA 2022 328(1) 57-68 - COVID-19 and Sickle Cell Disease: Frequently Asked Questions
American Society for Hematology, 2021 - Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia.
Batista Jéssica V G F, et al. Annals of hematology 2021 6 - Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers.
Figueiredo Camylla Vilas Boas, et al. PloS one 2021 0 (2) e0246067 - Using Artificial Intelligence to Predict Surgical Shunts in Men with Ischemic Priapism.
Masterson Thomas A et al. The Journal of urology 2020 Jun 101097JU0000000000001183 - Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study.
Cintho Ozahata Mina, et al. The journal of sexual medicine 2019 10
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 21, 2024
- Content source: